Cargando…
A regression based phase I clinical trial for late-onset toxicities without clinician elicitation
An extension of the isotonic regression based phase I clinical trial design is presented that incorporates partial follow-up times into estimation of the raw toxicity probabilities. This phase I clinical trial design, called the TITE-IR design, drastically decreases average trial duration by allowin...
Autores principales: | Chapple, Andrew G., Wojcik, Janusz J., McDaniel, Lee S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360989/ https://www.ncbi.nlm.nih.gov/pubmed/30766934 http://dx.doi.org/10.1016/j.conctc.2019.100327 |
Ejemplares similares
-
Design of an eccentric recumbent ergometer to elicit delayed onset muscle soreness
por: Harper, Sara A., et al.
Publicado: (2021) -
Subgroup‐specific dose finding for phase I‐II trials using Bayesian clustering
por: Curtis, Alexandra, et al.
Publicado: (2022) -
A Case of Late-Onset Gemcitabine Lung Toxicity
por: Sherrod, Amanda M., et al.
Publicado: (2011) -
Late-onset Bipolar I Disorder
por: Salem, Anthony, et al.
Publicado: (2018) -
Regression of Late Onset Choroidal Metastasis from a Breast Carcinoma with Letrozole
por: Cancino, Reinaldo, et al.
Publicado: (2011)